ENDOCRINOLOGY DEPARTMENT – CLINICAL TRIALS AND RESEARCH
European observational study of Pasireotide LAR in Megalacria – ACRONIS
Code: CSOM230CIC05
Support: Novartis Pharma Services AG
Effectiveness and safety observational study Afinitor® (everolimus) in patients with non surgically ressected or metastatic neuroendocrine pancreatic tumors G1 or G2 – PROTOR
Code: CRAD001PGR07
Support: Novartis Pharma Services AG
Double blind randomized controlled trial comparing effectiveness and safety of levoketoconazole (2S, 4R-ketoconazole) with placebo for the treatment of Endogenous Cushing Syndrome
Code: COR-2017-01
Support: Cortendo AB
ASPEN study: A Prospective Evaluation of the Management of Sporadic Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤2
Evaluation of denosumab in adult patients with Langerhans mast cell disease: multicentre open-label clinical trial
Code: 20159460
Αdaptation of the existing EORTC QLQ-GINET21 module to develop a specific module for use in patients with Pancreatic Neuroendocrine Tumor, Phases I to III
Clock gene expression in adrenal tumors (in association with the Biochemistry Research Laboratory, Medical School, E. Kassi)
Factors in Neuroendocrine Tunors of the Gastrointestinal Tract
Clock genes abnormalities in patients with autoimmune atrophic gastritis, hyperplasia of gastric muffin cells and carcinoid type I (in association with the Biochemistry Research Laboratory, Medical School, E. Kassi)
Autophagy pathway in Neuroendocrine Tumors of the Pancreas (in association with the Experimental Surgical Unit of the Biomedical Research Academy of Athens, E. Andreakos
Epigenetics and Osteoporosis (in association with the BioMedical Sciences Research Centre – 251 Aviation Forces General Hospital, P. Makras)
Disthrepsia and clinical outcome in patients with Neuroendocrine Tumors
Sarcopenia in patients with Neuroendocrine Tumors
Τhe clinical significance of metastatic bone disease in patients with advanced Gastrointestinal Neuroendocrine Tumors.
Long term follow-up in patients with Appendiceal Neuroendocrine Tumors (Appendiceal NEN)
Metastatic Gastric Neuroendocrine Neoplasms (NENs) type 1
Tumorigenesis in Pituitary
Comparative study of Magnetic Resonance Imaging (MRI) with Endoscopic Ultarsonography (EUS) in patients with Multiple Endocrine Neoplasia type 1 (MEN1)
Lung Metastasis in patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP NET)
Neuroendocrine tumors in Bone Metabolism
Capecitabine and Temozolomide (CAPTEM) στους NETs